<PAGE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------
SCHEDULE 14D-1
TENDER OFFER STATEMENT PURSUANT TO SECTION 14(d)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)
AND
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)
----------------
INCONTROL, INC.
(NAME OF SUBJECT COMPANY)
PEGASUS ACQUISITIONS CORP.
AN INDIRECT WHOLLY-OWNED SUBSIDIARY OF
GUIDANT CORPORATION
(BIDDERS)
----------------
COMMON STOCK, PAR VALUE $0.01 PER SHARE
(TITLE OF CLASS OF SECURITIES)
45336L103
(CUSIP NUMBER OF CLASS OF SECURITIES)
----------------
J.B. KING, ESQ.
GUIDANT CORPORATION
111 MONUMENT CIRCLE
INDIANAPOLIS, IN 46204-5129
(317) 971-2000
(NAMES, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE NOTICES
AND COMMUNICATIONS ON BEHALF OF BIDDER)
----------------
COPIES OF COMMUNICATIONS TO:
BERNARD E. KURY, ESQ.
JONATHAN L. FREEDMAN, ESQ.
DEWEY BALLANTINE LLP
1301 AVENUE OF THE AMERICAS
NEW YORK, NY 10019
(212) 259-8000
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
This Amendment No. 2 amends and supplements the Tender Offer Statement on
Schedule 14D-1/Schedule 13D, initially filed August 17, 1998, as amended (the
"Schedule 14D-1"), of Guidant Corporation, an Indiana corporation, and its
wholly-owned subsidiaries, Cardiac Pacemakers, Inc., a Minnesota corporation,
and Pegasus Acquisitions Corp., a Delaware corporation ("Purchaser"), relating
to Purchaser's tender offer for all of the outstanding stock of InControl,
Inc., a Delaware corporation, upon the terms and subject to the conditions set
forth in the Offer to Purchase, dated August 17, 1998 (the "Offer to
Purchase"). Unless otherwise defined herein, all capitalized terms used herein
shall have the respective meanings given such terms in the Offer to Purchase
or the Schedule 14D-1.
ITEM 10(a). ADDITIONAL INFORMATION.
The response to Item 10(a) is hereby amended and supplemented as follows:
On August 20, 1998, pursuant to the terms and conditions of the Credit
Agreement, Parent loaned $3,000,000 to the Company.
<PAGE>
SIGNATURE
After due inquiry and to the best of my knowledge and belief, each of the
undersigned certifies that the information set forth in this Statement is
true, complete and correct.
Dated: August 19, 1998
Pegasus Acquisitions Corp.
/s/ A. Jay Graf
By: _________________________________
A. Jay Graf
President
Cardiac Pacemakers, Inc.
/s/ A. Jay Graf
By: _________________________________
A. Jay Graf
President and Chief Executive
Officer
Guidant Corporation
/s/ A. Jay Graf
By: _________________________________
A. Jay Graf
Vice President
